CLINICAL_TRIALS
research
· 2025-10-07
Clinical Trial Update: Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease
Summary
University of Exeter is studying aquaporin-4 single nucleotide polymorphisms in people with idiopathic and familial Parkinson disease; the trial status is ACTIV…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Exeter | Conditions: Parkinson Disease | Status: ACTIVE_NOT_RECRUITING